"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LIVER.
| Descriptor ID |
D008113
|
| MeSH Number(s) |
C04.588.274.623 C06.301.623 C06.552.697
|
| Concept/Terms |
Liver Neoplasms- Liver Neoplasms
- Neoplasms, Hepatic
- Neoplasms, Liver
- Liver Neoplasm
- Neoplasm, Liver
- Hepatic Neoplasms
- Hepatic Neoplasm
- Neoplasm, Hepatic
Cancer of Liver- Cancer of Liver
- Hepatocellular Cancer
- Cancers, Hepatocellular
- Hepatocellular Cancers
- Hepatic Cancer
- Cancer, Hepatic
- Cancers, Hepatic
- Hepatic Cancers
- Liver Cancer
- Cancer, Liver
- Cancers, Liver
- Liver Cancers
- Cancer of the Liver
- Cancer, Hepatocellular
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".
This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 4 | 8 |
| 1997 | 1 | 2 | 3 |
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 3 | 4 |
| 2000 | 2 | 4 | 6 |
| 2001 | 7 | 1 | 8 |
| 2002 | 9 | 5 | 14 |
| 2003 | 5 | 3 | 8 |
| 2004 | 11 | 5 | 16 |
| 2005 | 9 | 3 | 12 |
| 2006 | 6 | 3 | 9 |
| 2007 | 15 | 3 | 18 |
| 2008 | 14 | 4 | 18 |
| 2009 | 15 | 6 | 21 |
| 2010 | 20 | 4 | 24 |
| 2011 | 19 | 5 | 24 |
| 2012 | 17 | 3 | 20 |
| 2013 | 26 | 3 | 29 |
| 2014 | 23 | 4 | 27 |
| 2015 | 23 | 4 | 27 |
| 2016 | 28 | 3 | 31 |
| 2017 | 29 | 4 | 33 |
| 2018 | 35 | 4 | 39 |
| 2019 | 44 | 6 | 50 |
| 2020 | 54 | 3 | 57 |
| 2021 | 45 | 4 | 49 |
| 2022 | 65 | 0 | 65 |
| 2023 | 54 | 2 | 56 |
| 2024 | 46 | 8 | 54 |
| 2025 | 28 | 1 | 29 |
| 2026 | 24 | 0 | 24 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.
-
Temporal changes in sex and race/ethnicity incidence rate ratios for hepatocellular carcinoma in the United States, 1992-2022. Cancer Causes Control. 2026 Aug 30; 37(9).
-
Noncanonical mTORC1-TFEB activation promotes hepatocyte plasticity and high-grade malignancy in hepatocellular carcinoma. J Clin Invest. 2026 Oct 01; 136(19).
-
Cost-effectiveness of HES V2.0 and GALAD for hepatocellular carcinoma surveillance in patients with cirrhosis. Hepatol Commun. 2026 Aug 01; 10(8).
-
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma. ESMO Open. 2026 Aug; 11(8):107771.
-
The changing epidemiology of primary liver cancer in the 21st century. J Hepatol. 2026 Oct; 85(4):656-668.
-
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions. Liver Int. 2026 07; 46(7):e70734.
-
Multi-ancestry genome-wide association meta-analysis of hepatocellular carcinoma identifies 15 risk loci including MAP3K9, DHRS1, MTTP, and 8q24.21. HGG Adv. 2026 Oct 08; 7(4):100639.
-
Laser-programmable glycosaminoglycan-based nanocarriers co-deliver hypocrellin B and doxorubicin for spatiotemporal chemo-photothermal therapy of hepatocellular carcinoma. Colloids Surf B Biointerfaces. 2026 Nov; 267:115919.
-
Biallelic ARID1A Alterations : A Promising Novel Biomarker for Risk Stratification and Management in Pediatric Malignant Hepatocellular Tumors. Am J Surg Pathol. 2026 09 01; 50(9):1106-1119.
-
Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors. Signal Transduct Target Ther. 2026 Jun 05; 11(1).